Volume 138, Issue 7, Pages e1 (June 2010)

Slides:



Advertisements
Similar presentations
Volume 152, Issue 5, Pages e1 (April 2017)
Advertisements

Volume 15, Issue 5, Pages (May 2016)
Peter L. Lee, Yuefeng Tang, Huawei Li, David A. Guertin 
Hypoglycemia After Gastric Bypass: The Dark Side of GLP-1
Alas! Ileal Interposition Surgery for Diabetes Prevention?
Volume 131, Issue 2, Pages (August 2006)
Volume 141, Issue 6, Pages e7 (December 2011)
Insulin-Like Growth Factor-1 Is Not Essential for the Intestinal Trophic Effects of Glucagon-Like Peptide-2  Prue Pereira–Fantini, Sarah Thomas, Julie.
Volume 138, Issue 4, Pages (April 2010)
An Unusual Cause of Lower Gastrointestinal Bleeding
Hypoglycemia After Gastric Bypass: The Dark Side of GLP-1
Volume 143, Issue 2, Pages e2 (August 2012)
An Albumin-Exendin-4 Conjugate Engages Central and Peripheral Circuits Regulating Murine Energy and Glucose Homeostasis  Laurie L. Baggio, Qingling Huang,
Substance P as a Novel Anti-obesity Target
Outcomes Among Living Liver Donors
Volume 135, Issue 6, Pages e2 (December 2008)
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Gastroenterology 2011–2016: Looking Back and Forward
Electronic Clinical Challenges and Images in GI
Volume 130, Issue 6, Pages (May 2006)
Volume 154, Issue 5, Pages (April 2018)
Volume 138, Issue 7, Pages e1 (June 2010)
Volume 15, Issue 1, Pages (January 2007)
Volume 137, Issue 6, Pages (December 2009)
Clinical Challenges and Images in GI
Volume 138, Issue 7, Pages e3 (June 2010)
Unusual Case of an Upset Stomach
Sang Pyo Lee, Hang Lak Lee, Kang Nyeong Lee  Gastroenterology 
Volume 150, Issue 7, Pages e1 (June 2016)
Volume 150, Issue 4, Pages (April 2016)
Volume 141, Issue 3, Pages (September 2011)
Volume 15, Issue 5, Pages (May 2016)
Volume 128, Issue 5, Pages (May 2005)
Volume 141, Issue 3, Pages e4 (September 2011)
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Volume 138, Issue 5, Pages (May 2010)
Metabolic comparison of one-anastomosis gastric bypass, single-anastomosis duodenal-switch, Roux-en-Y gastric bypass, and vertical sleeve gastrectomy.
Volume 134, Issue 3, Pages (March 2008)
Marzieh Salehi, Amalia Gastaldelli, David A. D'Alessio 
Volume 23, Issue 4, Pages (April 2018)
Volume 3, Issue 3, Pages (March 2006)
This Month in Gastroenterology
Daniel F. Wallace, Lesa Summerville, V. Nathan Subramaniam 
Covering the Cover Gastroenterology
Postprandial Uridine Physiology Is Altered by Obesity
Volume 132, Issue 5, Pages (May 2007)
PPARβ/δ Activation Induces Enteroendocrine L Cell GLP-1 Production
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Alas! Ileal Interposition Surgery for Diabetes Prevention?
Volume 133, Issue 2, Pages (August 2007)
Volume 144, Issue 1, Pages e5 (January 2013)
Gastric Rupture Gastroenterology
Volume 150, Issue 7, Pages (June 2016)
The Rise and Fall (and Rise?) of Endoscopic Anti-Reflux Procedures
Volume 156, Issue 6, Pages e1 (May 2019)
The Dawning of a New Editorial Board for Gastroenterology
Electronic Clinical Challenges and Images in GI
Daniel Mønsted Shabanzadeh, Lars Tue Sørensen, Torben Jørgensen 
Would Free Fatty Acids Enhance Treatment of Obesity?
Electronic Clinical Challenges and Images in GI
Electronic Clinical Challenges and Images in GI
Electronic Clinical Challenges and Images in GI
Esophageal Tumor After Radical Surgery for Gastric Cancer
Volume 27, Issue 11, Pages e3 (June 2019)
Volume 124, Issue 5, Pages (May 2003)
Volume 23, Issue 4, Pages (April 2018)
Electronic Clinical Challenges and Images in GI
Volume 18, Issue 3, Pages (January 2017)
The Stomach in Diabetes: From Villain to Ally
Unrelenting Abdominal Pain after Recent Initiation of a Direct Oral Anticoagulant: A Cause for Concern  Nicholas R. Crews, Nabil Fayad  Gastroenterology 
Presentation transcript:

Volume 138, Issue 7, Pages 2437-2446.e1 (June 2010) Ileal Interposition Surgery Improves Glucose and Lipid Metabolism and Delays Diabetes Onset in the UCD-T2DM Rat  Bethany P. Cummings, April D. Strader, Kimber L. Stanhope, James L. Graham, Jennifer Lee, Helen E. Raybould, Denis G. Baskin, Peter J. Havel  Gastroenterology  Volume 138, Issue 7, Pages 2437-2446.e1 (June 2010) DOI: 10.1053/j.gastro.2010.03.005 Copyright © 2010 AGA Institute Terms and Conditions

Figure 1 Kaplan–Meier analysis of diabetes incidence in sham-operated (n = 9) and IT-operated (n = 8) animals (A). *P < .05 by log-rank test. Fasting plasma glucose concentrations (B), food intake (C), and body weight (D) in sham-operated (n = 9) and IT-operated (n = 8) animals. *P < .05 disease × time by mixed procedures 3-factor (time, treatment, and disease-free days) RM ANOVA. Values are expressed as mean ± standard error of the mean. Gastroenterology 2010 138, 2437-2446.e1DOI: (10.1053/j.gastro.2010.03.005) Copyright © 2010 AGA Institute Terms and Conditions

Figure 2 Serum glucose (A), serum insulin (B), plasma GLP-17–36, (C) and plasma GIP (D) concentrations after an oral glucose gavage (1 g/kg of body weight, 50% dextrose solution) in sham- (n = 15) and IT-operated (n = 18) animals at 1 month after surgery. ***P < .0001, **P < .001 by 2-factor (time × treatment) ANOVA; *P < .05, **P < .01, ***P < .001 by Bonferroni's posttest. Ileal preproglucagon mRNA expression 2 months after surgery in sham- (n = 10) and IT-operated (n = 7) animals (E). Values are expressed as mean ± standard error of the mean. Gastroenterology 2010 138, 2437-2446.e1DOI: (10.1053/j.gastro.2010.03.005) Copyright © 2010 AGA Institute Terms and Conditions

Figure 3 Plasma total PYY concentrations after an oral intralipid gavage (1.5 g/kg of body weight, 20% lipid solution) at 3.5 months after surgery in sham- (n = 7) and IT-operated (n = 7) animals (A). *P < .05 by 2-factor (time × treatment) ANOVA; *P < .05, **P < .01 by Bonferroni's posttest. Ileal PYY mRNA expression 2 months after surgery in sham- (n = 10) and IT-operated (n = 7) animals (B). *P < .05 by Student's t test. Values are expressed as mean ± standard error of the mean. Gastroenterology 2010 138, 2437-2446.e1DOI: (10.1053/j.gastro.2010.03.005) Copyright © 2010 AGA Institute Terms and Conditions

Figure 4 Representative images of pancreas sections from prediabetic sham- and IT-operated animals at 2 months after surgery. H&E stain of pancreas sections from sham-operated (A) and IT-operated (D) animals. Anti-insulin immunostaining of pancreas sections from sham-operated (B) and IT-operated (E) animals. Antiglucagon immunostaining of pancreas sections from sham- (C) and IT-operated (F) animals. Gastroenterology 2010 138, 2437-2446.e1DOI: (10.1053/j.gastro.2010.03.005) Copyright © 2010 AGA Institute Terms and Conditions

Figure 5 Monthly measurements of fasting plasma TG (A), cholesterol (B), insulin (D), adiponectin (E), and leptin (F) concentrations in sham- (n = 9) and IT-operated (n = 8) animals. +P < .05, +++P < .001 treatment × time; *P < .05, **P < .01, ***P < .001 disease × time by mixed procedures 3-factor (time, treatment, and disease-free days) RM ANOVA. Fasting plasma bile acids at 2 months after surgery in sham- (n = 10) and IT-operated (n = 10) animals (C). *P < .05 by Student's t test. Values are expressed as mean ± standard error of the mean. Gastroenterology 2010 138, 2437-2446.e1DOI: (10.1053/j.gastro.2010.03.005) Copyright © 2010 AGA Institute Terms and Conditions

Figure 6 Mesenteric (A) and subcutaneous cell (C) volume distribution and mesenteric (B) and subcutaneous (D) peak cell volume. *P < .05, ***P < .001 by Student's t test. Values are expressed as mean ± standard error of the mean. Gastroenterology 2010 138, 2437-2446.e1DOI: (10.1053/j.gastro.2010.03.005) Copyright © 2010 AGA Institute Terms and Conditions

Supplemental Figure 1 Representative Western blots of nodose ganglion glucagon-like peptide-1 receptor (GLP-1R) and neuropeptide Y receptor type 2 (NPY2R) protein levels. Images presented were taken from the same gel (A). Quantification of nodose ganglion GLP-1R and NPY2R protein levels (B). Sham: n = 10, ileal interposition (IT): n = 10. Values are expressed as mean ± standard error of the mean. Gastroenterology 2010 138, 2437-2446.e1DOI: (10.1053/j.gastro.2010.03.005) Copyright © 2010 AGA Institute Terms and Conditions